Chargement en cours...

Absence of deletions but frequent loss of expression of p16INK4 in human ovarian tumours.

The cyclin-dependent kinase inhibitor p16 gene (P16, MTS1, CDKN2) has been shown to be altered by deletion or point mutation in some human tumours and cancer cell lines, suggesting that it works as a tumour suppressor. We analysed p16 gene mutation and p16 protein expression in 42 primary ovarian ca...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: Marchini, S., Codegoni, A. M., Bonazzi, C., Chiari, S., Broggini, M.
Format: Article
Langue:English
Publié: Nature Publishing Group 1997
Sujets:
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC2223926/
https://ncbi.nlm.nih.gov/pubmed/9231912
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!